Evaluation of a new high-dimensional miRNA profiling platform

Julie M Cunningham, Ann L Oberg, Pedro M. Borralho, Betsy T. Kren, Amy J. French, Liang Wang, Brian M. Bot, Bruce W. Morlan, Kevin At Silverstein, Rod Staggs, Yan Zeng, Anne Francoise Lamblin, Christopher A. Hilker, Jian Bing Fan, Clifford J. Steer, Stephen N Thibodeau

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background. MicroRNAs (miRNAs) are a class of approximately 22 nucleotide long, widely expressed RNA molecules that play important regulatory roles in eukaryotes. To investigate miRNA function, it is essential that methods to quantify their expression levels be available. Methods. We evaluated a new miRNA profiling platform that utilizes Illumina's existing robust DASL chemistry as the basis for the assay. Using total RNA from five colon cancer patients and four cell lines, we evaluated the reproducibility of miRNA expression levels across replicates and with varying amounts of input RNA. The beta test version was comprised of 735 miRNA targets of Illumina's miRNA profiling application. Results. Reproducibility between sample replicates within a plate was good (Spearman's correlation 0.91 to 0.98) as was the plate-to-plate reproducibility replicates run on different days (Spearman's correlation 0.84 to 0.98). To determine whether quality data could be obtained from a broad range of input RNA, data obtained from amounts ranging from 25 ng to 800 ng were compared to those obtained at 200 ng. No effect across the range of RNA input was observed. Conclusion. These results indicate that very small amounts of starting material are sufficient to allow sensitive miRNA profiling using the Illumina miRNA high-dimensional platform. Nonlinear biases were observed between replicates, indicating the need for abundance-dependent normalization. Overall, the performance characteristics of the Illumina miRNA profiling system were excellent.

Original languageEnglish (US)
Article number57
JournalBMC Medical Genomics
Volume2
DOIs
StatePublished - 2009

Fingerprint

MicroRNAs
RNA
Eukaryota
Colonic Neoplasms
Nucleotides
Cell Line

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Evaluation of a new high-dimensional miRNA profiling platform. / Cunningham, Julie M; Oberg, Ann L; Borralho, Pedro M.; Kren, Betsy T.; French, Amy J.; Wang, Liang; Bot, Brian M.; Morlan, Bruce W.; Silverstein, Kevin At; Staggs, Rod; Zeng, Yan; Lamblin, Anne Francoise; Hilker, Christopher A.; Fan, Jian Bing; Steer, Clifford J.; Thibodeau, Stephen N.

In: BMC Medical Genomics, Vol. 2, 57, 2009.

Research output: Contribution to journalArticle

Cunningham, JM, Oberg, AL, Borralho, PM, Kren, BT, French, AJ, Wang, L, Bot, BM, Morlan, BW, Silverstein, KA, Staggs, R, Zeng, Y, Lamblin, AF, Hilker, CA, Fan, JB, Steer, CJ & Thibodeau, SN 2009, 'Evaluation of a new high-dimensional miRNA profiling platform', BMC Medical Genomics, vol. 2, 57. https://doi.org/10.1186/1755-8794-2-57
Cunningham, Julie M ; Oberg, Ann L ; Borralho, Pedro M. ; Kren, Betsy T. ; French, Amy J. ; Wang, Liang ; Bot, Brian M. ; Morlan, Bruce W. ; Silverstein, Kevin At ; Staggs, Rod ; Zeng, Yan ; Lamblin, Anne Francoise ; Hilker, Christopher A. ; Fan, Jian Bing ; Steer, Clifford J. ; Thibodeau, Stephen N. / Evaluation of a new high-dimensional miRNA profiling platform. In: BMC Medical Genomics. 2009 ; Vol. 2.
@article{5fd53a48628e4b149a243fd2155807c4,
title = "Evaluation of a new high-dimensional miRNA profiling platform",
abstract = "Background. MicroRNAs (miRNAs) are a class of approximately 22 nucleotide long, widely expressed RNA molecules that play important regulatory roles in eukaryotes. To investigate miRNA function, it is essential that methods to quantify their expression levels be available. Methods. We evaluated a new miRNA profiling platform that utilizes Illumina's existing robust DASL chemistry as the basis for the assay. Using total RNA from five colon cancer patients and four cell lines, we evaluated the reproducibility of miRNA expression levels across replicates and with varying amounts of input RNA. The beta test version was comprised of 735 miRNA targets of Illumina's miRNA profiling application. Results. Reproducibility between sample replicates within a plate was good (Spearman's correlation 0.91 to 0.98) as was the plate-to-plate reproducibility replicates run on different days (Spearman's correlation 0.84 to 0.98). To determine whether quality data could be obtained from a broad range of input RNA, data obtained from amounts ranging from 25 ng to 800 ng were compared to those obtained at 200 ng. No effect across the range of RNA input was observed. Conclusion. These results indicate that very small amounts of starting material are sufficient to allow sensitive miRNA profiling using the Illumina miRNA high-dimensional platform. Nonlinear biases were observed between replicates, indicating the need for abundance-dependent normalization. Overall, the performance characteristics of the Illumina miRNA profiling system were excellent.",
author = "Cunningham, {Julie M} and Oberg, {Ann L} and Borralho, {Pedro M.} and Kren, {Betsy T.} and French, {Amy J.} and Liang Wang and Bot, {Brian M.} and Morlan, {Bruce W.} and Silverstein, {Kevin At} and Rod Staggs and Yan Zeng and Lamblin, {Anne Francoise} and Hilker, {Christopher A.} and Fan, {Jian Bing} and Steer, {Clifford J.} and Thibodeau, {Stephen N}",
year = "2009",
doi = "10.1186/1755-8794-2-57",
language = "English (US)",
volume = "2",
journal = "BMC Medical Genomics",
issn = "1755-8794",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Evaluation of a new high-dimensional miRNA profiling platform

AU - Cunningham, Julie M

AU - Oberg, Ann L

AU - Borralho, Pedro M.

AU - Kren, Betsy T.

AU - French, Amy J.

AU - Wang, Liang

AU - Bot, Brian M.

AU - Morlan, Bruce W.

AU - Silverstein, Kevin At

AU - Staggs, Rod

AU - Zeng, Yan

AU - Lamblin, Anne Francoise

AU - Hilker, Christopher A.

AU - Fan, Jian Bing

AU - Steer, Clifford J.

AU - Thibodeau, Stephen N

PY - 2009

Y1 - 2009

N2 - Background. MicroRNAs (miRNAs) are a class of approximately 22 nucleotide long, widely expressed RNA molecules that play important regulatory roles in eukaryotes. To investigate miRNA function, it is essential that methods to quantify their expression levels be available. Methods. We evaluated a new miRNA profiling platform that utilizes Illumina's existing robust DASL chemistry as the basis for the assay. Using total RNA from five colon cancer patients and four cell lines, we evaluated the reproducibility of miRNA expression levels across replicates and with varying amounts of input RNA. The beta test version was comprised of 735 miRNA targets of Illumina's miRNA profiling application. Results. Reproducibility between sample replicates within a plate was good (Spearman's correlation 0.91 to 0.98) as was the plate-to-plate reproducibility replicates run on different days (Spearman's correlation 0.84 to 0.98). To determine whether quality data could be obtained from a broad range of input RNA, data obtained from amounts ranging from 25 ng to 800 ng were compared to those obtained at 200 ng. No effect across the range of RNA input was observed. Conclusion. These results indicate that very small amounts of starting material are sufficient to allow sensitive miRNA profiling using the Illumina miRNA high-dimensional platform. Nonlinear biases were observed between replicates, indicating the need for abundance-dependent normalization. Overall, the performance characteristics of the Illumina miRNA profiling system were excellent.

AB - Background. MicroRNAs (miRNAs) are a class of approximately 22 nucleotide long, widely expressed RNA molecules that play important regulatory roles in eukaryotes. To investigate miRNA function, it is essential that methods to quantify their expression levels be available. Methods. We evaluated a new miRNA profiling platform that utilizes Illumina's existing robust DASL chemistry as the basis for the assay. Using total RNA from five colon cancer patients and four cell lines, we evaluated the reproducibility of miRNA expression levels across replicates and with varying amounts of input RNA. The beta test version was comprised of 735 miRNA targets of Illumina's miRNA profiling application. Results. Reproducibility between sample replicates within a plate was good (Spearman's correlation 0.91 to 0.98) as was the plate-to-plate reproducibility replicates run on different days (Spearman's correlation 0.84 to 0.98). To determine whether quality data could be obtained from a broad range of input RNA, data obtained from amounts ranging from 25 ng to 800 ng were compared to those obtained at 200 ng. No effect across the range of RNA input was observed. Conclusion. These results indicate that very small amounts of starting material are sufficient to allow sensitive miRNA profiling using the Illumina miRNA high-dimensional platform. Nonlinear biases were observed between replicates, indicating the need for abundance-dependent normalization. Overall, the performance characteristics of the Illumina miRNA profiling system were excellent.

UR - http://www.scopus.com/inward/record.url?scp=70349260261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349260261&partnerID=8YFLogxK

U2 - 10.1186/1755-8794-2-57

DO - 10.1186/1755-8794-2-57

M3 - Article

C2 - 19712457

AN - SCOPUS:70349260261

VL - 2

JO - BMC Medical Genomics

JF - BMC Medical Genomics

SN - 1755-8794

M1 - 57

ER -